Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Liver transplantation1521 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A09957 | 31543676 | World J Gastroenterol | Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. | 2019 | Details |
A09958 | 31543468 | Ann Hepatol | Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis. | 2019 | Details |
A09959 | 31543467 | Ann Hepatol | Obesity and liver cancer. | 2019 | Details |
A09982 | 31537030 | Semin Liver Dis | Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH). | 2019 | Details |
A10035 | 31518478 | Liver Transpl | Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5-Year Experience. | 2019 | Details |
A10042 | 31516267 | J Clin Exp Hepatol | Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How? | 2019 | Details |
A10043 | 31516266 | J Clin Exp Hepatol | Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective. | 2019 | Details |
A10044 | 31516265 | J Clin Exp Hepatol | Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective. | 2019 | Details |
A10083 | 31495973 | Hepatol Res | Phase 3 drug pipelines in the treatment of non-alcoholic steatohepatitis. | 2019 | Details |
A10191 | 31441967 | Clin Transplant | A review of the use of transient elastography in the assessment of fibrosis and steatosis in the post-liver transplant patient. | 2019 | Details |
A10199 | 31437349 | Am J Transplant | Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades. | 2019 | Details |
A10209 | 31431413 | HPB (Oxford) | Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis. | 2019 | Details |
A10241 | 31415032 | Transplantation | Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis. | 2019 | Details |
A10245 | 31413528 | World J Gastroenterol | Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm? | 2019 | Details |
A10277 | 31402253 | Transplant Proc | A Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey. | 2019 | Details |
A10278 | 31402248 | Transplant Proc | The Utility of Noninvasive Scoring Systems for Prediction of Hepatic Steatosis in Liver Transplantation Donor Candidates. | 2019 | Details |
A10285 | 31399173 | Transplant Proc | Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients. | 2019 | Details |
A10296 | 31394730 | Cells | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). | 2019 | Details |
A10297 | 31394020 | Am J Transplant | The decreasing predictive power of MELD in an era of changing etiology of liver disease. | 2019 | Details |
A10324 | 31387736 | Lancet Gastroenterol Hepatol | Management of metabolic syndrome and cardiovascular risk after liver transplantation. | 2019 | Details |
A10380 | 31363910 | Hepatol Int | Reversal of NASH fibrosis with pharmacotherapy. | 2019 | Details |
A10387 | 31360022 | J Clin Exp Hepatol | The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation. | 2018 | Details |
A10396 | 31356578 | Transplantation | Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation. | 2020 | Details |
A10461 | 31326267 | J Diabetes Complications | Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis. | 2019 | Details |
A10480 | 31319186 | Clin Gastroenterol Hepatol | Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in Australia. | 2019 | Details |
A10492 | 31312990 | Dig Dis Sci | Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. | 2019 | Details |
A10522 | 31303681 | J Okla State Med Assoc | Overview of Pediatric Nonalcoholic Fatty Liver Disease: A Guide for General Practitioners. | 2018 | Details |
A10545 | 31293441 | Front Physiol | The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH). | 2019 | Details |
A10633 | 31260793 | Contemp Clin Trials | REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis. | 2019 | Details |
A10657 | 31251379 | JAMA Netw Open | Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis. | 2019 | Details |
A10717 | 31225483 | Cell Stress | Foie gras and liver regeneration: a fat dilemma. | 2018 | Details |
A10728 | 31219486 | Saudi Med J | Position statement on the diagnosis and management of non-alcoholic fatty liver disease. | 2019 | Details |
A10825 | 31172417 | Hepatol Int | Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. | 2019 | Details |
A10869 | 31149341 | Pharmacol Res Perspect | A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH). | 2019 | Details |
A10872 | 31146627 | Prog Transplant | Effects of Share 35 Policy on Liver Transplantation Outcomes for Patients With Nonalcoholic Steatohepatitis. | 2019 | Details |
A10934 | 31114547 | Front Endocrinol (Lausanne) | Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients. | 2019 | Details |
A10940 | 31113580 | Ann Hepatol | miR-182-5p Attenuates High-Fat -Diet-Induced Nonalcoholic Steatohepatitis in Mice. | 2020 | Details |
A11025 | 31078545 | Life Sci | Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice. | 2019 | Details |
A11042 | 31071367 | J Hepatol | Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study. | 2019 | Details |
A11060 | 31062641 | Adipocyte | PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease. | 2019 | Details |
A11062 | 31061949 | Hepatol Commun | Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment. | 2019 | Details |
A11118 | 31034092 | Hepatology | Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum. | 2019 | Details |
A11177 | 31010049 | Int J Mol Sci | Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. | 2019 | Details |
A11194 | 31004758 | Clin Gastroenterol Hepatol | Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies. | 2019 | Details |
A11206 | 30999770 | Scand J Gastroenterol | Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation. | 2019 | Details |
A11257 | 30972062 | Front Immunol | Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease. | 2019 | Details |
A11319 | 30940296 | Gene Expr | Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment. | 2019 | Details |
A11351 | 30927288 | Clin Transplant | The impact of post-transplant diabetes mellitus on liver transplant outcomes. | 2019 | Details |
A11365 | 30920975 | Eur J Gastroenterol Hepatol | Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial. | 2019 | Details |
A11375 | 30919331 | Adv Exp Med Biol | Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions. | 2019 | Details |
A11379 | 30918425 | World J Gastroenterol | Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. | 2019 | Details |
A11404 | 30908822 | Intern Med J | Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme. | 2019 | Details |
A11450 | 30889791 | Medicines (Basel) | The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A11468 | 30882933 | Aliment Pharmacol Ther | Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease. | 2019 | Details |
A11561 | 30839326 | Am J Gastroenterol | Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients. | 2019 | Details |
A11585 | 30829446 | Liver Int | Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis. | 2019 | Details |
A11587 | 30828530 | Adv Sci (Weinh) | Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases. | 2018 | Details |
A11611 | 30820265 | World J Hepatol | Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects. | 2019 | Details |
A11629 | 32461811 | Liver Res | The role of gut microbiota in liver disease development and treatment. | 2019 | Details |
A11630 | 30811890 | Am J Transplant | OPTN/SRTR 2017 Annual Data Report: Liver. | 2019 | Details |
A11636 | 30809932 | Liver Int | Evidence of bias during liver transplant evaluation of non-alcoholic steatohepatitis cirrhosis patients. | 2019 | Details |
A11681 | 30791794 | Expert Rev Gastroenterol Hepatol | Sarcopenia and chronic liver diseases. | 2018 | Details |
A11683 | 30791782 | Expert Rev Gastroenterol Hepatol | Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. | 2018 | Details |
A11684 | 30791778 | Expert Rev Gastroenterol Hepatol | Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times. | 2018 | Details |
A11707 | 30783901 | Hepatol Int | End-points for drug treatment in NASH. | 2019 | Details |
A11775 | 30755499 | Clin Sci (Lond) | Emerging awareness on the importance of skeletal muscle in liver diseases: time to dig deeper into mechanisms! | 2019 | Details |
A11796 | 30737662 | Inflammation | Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis. | 2019 | Details |
A11805 | 30732664 | Proc Nutr Soc | Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum. | 2019 | Details |
A11902 | 30687780 | Hepatoma Res | Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation. | 2018 | Details |
A11940 | 30673619 | Cell Rep | Impaired LXRα Phosphorylation Attenuates Progression of Fatty Liver Disease. | 2019 | Details |
A12011 | 30645665 | Internist (Berl) | [New aspects of nonalcoholic steatohepatitis]. | 2019 | Details |
A12084 | 30609189 | Liver Transpl | Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. | 2019 | Details |
A12085 | 30609187 | Liver Transpl | Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand. | 2019 | Details |
A12144 | 30582966 | Biochim Biophys Acta Mol Basis Dis | Prognostic molecular markers in pediatric liver disease - Are there any? | 2018 | Details |
A12153 | 30580093 | Clin Gastroenterol Hepatol | Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug-Induced Liver Injury. | 2018 | Details |
A12176 | 30574191 | Therap Adv Gastroenterol | Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease. | 2018 | Details |
A12188 | 30569183 | Eur Radiol | CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard. | 2018 | Details |
A12201 | 30564000 | J Clin Exp Hepatol | Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A12213 | 30560336 | Dig Dis Sci | Incidence of Recurrent NASH-Related Allograft Cirrhosis. | 2018 | Details |
A12223 | 30556145 | Hepatology | Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A12247 | 30548128 | Liver Transpl | Fibrinolysis Shutdown Is Associated With Thrombotic and Hemorrhagic Complications and Poorer Outcomes After Liver Transplantation. | 2019 | Details |
A12253 | 30545408 | J Med Case Rep | Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports. | 2018 | Details |
A12268 | 30540727 | Rev Gastroenterol Peru | [Hepatopulmonar syndrome and liver transplantation: experience in the transplantation department of the Guillermo Almenara Irigoyen National Hospital - EsSalud]. | 2019 | Details |
A12269 | 30540726 | Rev Gastroenterol Peru | [Liver transplant and hepatocellular carcinoma in Peru: outcome after 15 years in the transplant department of the Guillermo Almenara Hospital - EsSalud]. | 2019 | Details |
A12275 | 30537758 | Digestion | Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research. | 2018 | Details |
A12305 | 30507741 | Transplantation | Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes. | 2019 | Details |
A12308 | 30506586 | Hepatology | Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis. | 2019 | Details |
A12373 | 30482910 | Nat Rev Gastroenterol Hepatol | The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2019 | Details |
A12385 | 30474191 | Diabet Med | Utility of HbA1c assessment in people with diabetes awaiting liver transplantation. | 2019 | Details |
A12443 | 30454826 | Clin Liver Dis | Alcohol-Associated Cirrhosis. | 2019 | Details |
A12452 | 30451739 | Transplantation | Future Trends in Demand for Liver Transplant: Birth Cohort Effects Among Patients With NASH and HCC. | 2019 | Details |
A12454 | 30448600 | Clin Gastroenterol Hepatol | Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis. | 2018 | Details |
A12471 | 30441981 | Vnitr Lek | Future of pharmacological treatment of non-alcoholic steatohepatitis in terms of key pathophysiological mechanisms. | 2019 | Details |
A12489 | 30427105 | Liver Int | Metabolic factors affecting hepatocellular carcinoma in steatohepatitis. | 2018 | Details |
A12499 | 30420265 | Arab J Gastroenterol | Managing diabetes and liver disease association. | 2018 | Details |
A12501 | 30418431 | Transplantation | Steatosis in Liver Transplantation: Current Limitations and Future Strategies. | 2019 | Details |
A12510 | 30414863 | J Hepatol | Non-alcoholic fatty liver disease - A global public health perspective. | 2018 | Details |
A12594 | 30371253 | J Am Heart Assoc | Liver Disease as a Predictor of New-Onset Atrial Fibrillation. | 2018 | Details |
A12597 | 30369023 | Liver Transpl | Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis. | 2019 | Details |
A12598 | 30369002 | Liver Transpl | Impact of Prior Bariatric Surgery on Perioperative Liver Transplant Outcomes. | 2019 | Details |